Method for reducing biofilm formation

ABSTRACT

A two phase method for reducing the formation of biofilm includes an evacuation of ambient air from a region about the surgical or treatment site, to extract airborne or aerosolized bacteria ejected from the site by the treatment. The extracted bacteria are prevented from settling back onto the cleansed tissue surface, thus at least reducing colonial bacteriological growth and concomitantly exuded biofilm material. A second phase involves the attachment of one or more ultrasonic transducers to the patient over or near a surgical treatment site after the surgery is terminated. Each applied ultrasonic transducer is used to vibrate the patient&#39;s tissues at the treatment site to disrupt biofilm formation.

BACKGROUND OF THE INVENTION

This invention relates to apparatus and method for reducing biofilm on awound site particularly a wound site that is being debrided to removenecrotic tissue.

Chronic wound infection represents a significant healthcare problemworldwide. Often the end objective of wound healing is the objective fornew therapeutic options. Yet chronic wounds compromise a number ofdifferent and complex conditions that each interferes with the healingprocess. For example, a chronic wound can comprise necrotic tissue inneed of debridement, bacterial infection in need of antimicrobial agentsand compromised vasculature that impedes the normal healing process.

One element of the chronic wound infection condition that impedeshealing is the formation of biofilm. Biofilm is the result of planktonicbacteria forming together and secreting exopolysaccharide (EPS) toadhere and protect the colonizing community. At the height of formation,EPS can make up between 75-90% of the total biofilm composition (Regt).Biofilm inhibits healing by creating an optimal condition for bacteriato grow, while simultaneously preventing antimicrobial agents fromdirect access to bacteria.

Methods to remove biofilm include ultrasonic debridement, topicalantimicrobials, suction, and surface cleansing. Each of these methodsalone treat an aspect of biofilm. For example, ultrasonic debridement ofwounds has proven to be the most effective mechanism in disrupting anddebulking a majority of the biofilm formation. Yet even in thispreferred method, biofilm debris can be left behind to propagate.Suction alone has not proven to be effective in removing biofilm, andcan potentially interfere with the operation of other methods likeultrasonic debridement if applied simultaneously.

U.S. Pat. No. 7,608,054 to Soring et al. describes a medical treatmentapparatus that combines an ultrasound sonotrode with a suction sheath.The fixed position between the tip of the suction and the tip of thesonotrode only allows for one simultaneous operation. In particular thisapproach is limited due to the potential interference of the suction tipduring the ultrasonic debridement operation.

U.S. Pat. No. 7,522,955 B2 to Rontal et al. describes a method andapparatus for ultrasonic cleaning of biofilm coated surfaces for sinuscavities within a human head. The method describes an ultrasonicapplication in combination with irrigation and suction that is designedto not remove any of the surrounding underlying tissue. This differssignificantly from an ultrasonic debridement of a wound bed, whichrequires the removal of tissue in combination with biofilm. Thus theultrasonic probe needs to operate in a cavitation mode at the surface ofa wound, causing destruction of the biofilm.

Methods of mechanical removal of biofilm in wounds alone have proven tobe inadequate. What does not exist and what would be beneficial to themarket is a method to remove biofilm and prevent it from reforming inorder to allow wounds to heal.

OBJECTS OF THE INVENTION

It is an object of the present invention to provide a method to inhibitbiofilm formation in order to allow wounds to heal more expeditiously.

A related object of the present invention is to provide a method forremoving biofilm so as to reduce the likelihood of the biofilmreforming.

Another related object of the present invention is to provide a methodto remove biofilm and prevent it from reforming in order to allow woundsto heal.

An associated object of the present invention is to provide apparatusfor removing biofilm with structure to assist in biofilm reformationreduction.

Another associated object of the present invention is to provideapparatus for inhibiting the formation of biofilm.

Although every feature of the invention is attained in at least oneembodiment of the invention, there is not necessarily any one embodimentthat achieves all of the objects of the invention.

SUMMARY OF THE INVENTION

The present invention broadly contemplates a method for the inhibitionof biofilm, a method for reducing the likelihood of biofilm formation.The method includes a surgical room cleansing process and a disruptionand removal. The method typically includes a mechanical debridement forthe removal of any existing necrotic tissue, surface infection orpreviously formed biofilm. The mechanical debridement process results ina clean wound bed of healthy granulated tissue. Substantiallyimmediately following the mechanical debridement of a wound, anultrasound biofilm disrupter pad is placed on or near the wound toprevent bacterial adherence to the wound bed by excretion of EPS.

The ultrasound biofilm disrupter prevents adherence of bacteria to thewound by application of surface acoustic waves at a sufficient frequencyand amplitude to disrupt formation but below a threshold that stimulatesbacterial growth. In order to accomplish this, a wound-dressing device,which incorporates a disposable ultrasonic transducer, is applied to thewound site post debridement for duration sufficient to allow healing tooccur.

In a preferred embodiment ultrasound is used in the debridement processto mechanically remove necrotic tissue while cleansing the wound bed.The ultrasonic debridement should be in the 20 kHz frequency range inorder to simultaneously begin the process of biofilm disruption. Oncethe mechanical debridement is complete, a lower energy setting on thedebridement probe may be utilized to pre-condition the wound bed fordisrupting adherence or starting the formation of biofilm. Preferably,the wound bed is immediately covered with a wound dressing thatincorporates an ultrasonic biofilm disrupter transducer delivering asurface acoustic wave at 20 kHz with an acoustic power output of 0.2-0.4w/cm². The transducer is connected to a portable energy source. Theenergy source can be battery supplied. The wound dressing canincorporate an antimicrobial agent that is delivered during the biofilmdisruption treatment.

In another embodiment ultrasound is incorporated into the wound dressingand applied after standard wound cleansing protocols have beenadministered. These protocols can include saline wash, topicalantimicrobial agents applied. The combination of ultrasonic debridement,low-pulsed ultrasonic biofilm disruption and topical antimicrobialsproduces an important sequential approach to the management and removalof biofilm. The removal of biofilm results in the removal of animpediment to the wound healing process.

In another embodiment ultrasound is combined with suction to create anoptimal combination for disruption and removal of biofilm. One stage ofbiofilm is an excretion of seeding stage. So existing debridementprocesses can result in a bulking of the biofilm, but at the same time aseeding of the newly created wound bed. The seeding process can occurfrom a mechanical debridement alone. In this the process for biofilmdisruption is temporary at best. To correct this problem, ultrasonicdebridement is combined with a suction process that collects themechanically removed biofilm remnants or seeding agents.

In one embodiment of this combined ultrasound and suction approach, theultrasonic debridement probe is housed by a suction probe that operatesin two stages. The first stage is with the ultrasonic debridement probeengaged with the tissue and the suction tip surrounding the debridementtip so that it is in near contact to the tissue simultaneously to removethe mechanically disrupted biofilm. In the second stage of operation thesuction tip can be moved to a position that is not in contact or nearcontact with the tissue, but sufficient enough to capture any biofilmdebris that is propelled into the area.

In another embodiment the combination of ultrasound and suction may haveone or more stages of operation. The positioning of the suction tip inrelationship to the ultrasound tip can be configured for a variety ofdifferent combinations to cause better mechanical disruption and captureof that disrupted biofilm. The combination of both ultrasonic energy tocause debridement and suction to cause removal can be done in a varietyof different sequences. For example, ultrasonic mechanical debridementcan be performed on the majority of the wound bed prior to engagingsuction to capture any remnant amounts of biofilm on the wound bed. Inanother embodiment the ultrasonic mechanical debridement is performedsimultaneous to applying suction either at the tip or near the tip.

In another embodiment the suction is incorporated into the ultrasonicdebridement probe to allow for a mechanical disruption and capture ofthe biofilm. In one embodiment the suction is at the periphery of theultrasonic debridement probe to allow for maximum capture of themechanically disrupted biofilm.

In another embodiment, the suction is interspersed throughout theultrasonic debridement probe so that any area of mechanical disruptionhas a corresponding area of capture capability.

In another embodiment, a disposable sheath incorporates a suctioncapability for capturing biofilm during an ultrasonic debridement. Inone embodiment the sheath has a multiple position for use during anultrasonic debridement. The sheath can capture both the debris that isexpelled during the debridement and any remaining debris at the surfaceof the wound bed The sheath can then be disposed of to avoid risk ofcross contamination. The sheath may incorporate a sealing strategy tomaintain suction pressure while still allowing for multi positioning onthe suction tip in relationship to the ultrasonic debridement tip.

Accordingly, a medical therapeutic method pursuant to one aspect of thepresent invention utilizes an ultrasonic debridement instrument havingan operative tip and a suction channel. The method comprises (i)manipulating the instrument to place the operative tip against apatient's tissues at a preselected surgical site, (ii) during contact ofthe operative tip with the patient's tissues, generating an ultrasonicstanding wave in the instrument, thereby fragmenting necrotic tissue andundesired organic material at the surgical site, (iii) during thegenerating of the ultrasonic standing wave, disposing a suction inlet ata distal end of the suction channel proximate the surgical site and (iv)applying vacuum or negative pressure to the suction channel to removetissue debris fragmented organic material from the surgical site via thesuction inlet, (v) disposing a suction port at a position spaced fromthe surgical site, and (vi) during and/or after the generating of theultrasonic standing wave and the fragmenting of tissue and material,sucking ambient air from a region about the surgical site through thesuction port at the position.

Preferably, the suction port is provided on the ultrasonic debridementinstrument, and the method includes operating an actuator to enable thesucking of air through the suction port.

In one embodiment of the instrument, the actuator may include a sheathor sleeve which is slidably mounted to the instrument for longitudinalmotion alternately in opposing directions along the shaft or probeportion thereof. The operating of the actuator then includes shiftingthe sheath or sleeve in a proximal direction along the instrument. Wherethe instrument includes a longitudinally shiftable sheath or sleeve,with the suction channel being located between the sheath or sleeve anda shaft or horn of the instrument, the suction inlet and the suctionport may both be defined by the distal end of the sheath or sleeve, theposition of the sleeve determining whether an intake opening is locatedat the operative tip of the instrument, and is thus the suction inlet,or is spaced from the operative tip and is therefore the suction port.Accordingly, the method may further comprise shifting the sheath orsleeve in a proximal direction after the applying of a vacuum ornegative pressure and prior to the sucking of the ambient air throughthe suction port, a distal tip of the sheath or sleeve defining thesuction inlet in a distal position of the sheath or sleeve, the distaltip defining the suction port in a proximal position of the sheath orsleeve.

In one or more alternative embodiments the suction inlet and the suctionport may be different and always mutually spaced from one another. Ifthe instrument includes a slidable sheath or sleeve, the position ofthat element may determine whether the suction inlet and/or the suctionport is active. Thus, the sheath or sleeve may include valves foropening and closing air pathways extending to the suction inlet and thesuction port, in dependence on the longitudinal position of the sheathor sleeve. Alternatively, valves may be operated separately viarespective electromechanical actuators so that the opening and closingof the suction inlet is controllable independently of the opening andclosing of the suction port.

Thus, where the suction port is different from the suction inlet, thesuction port being located proximally along the instrument from thesuction input, the operating of the actuator may include directingsuction under-pressure to the suction port. The actuation may includeoperating a valve to open a suction pathway to the suction port.

In accordance with another feature of the invention, the method mayalternatively or additionally comprise placing an ultrasonic transduceron the patient at least proximate the surgical site after terminating ofa debridement process and while the surgical site is free of discerniblebacteria. Typically, the transducer is placed immediately after thesurgical site has been cleaned of necrotic tissue and other undesirabledebris and even prior to the removal of the patient from the operatingroom. After the placing of the transducer and while the transducer is ineffective vibration-transmitting contact with the patient, an electricalenergization waveform of an ultrasonic frequency is conducted to thetransducer at least intermittently during a period of approximately oneday or longer to prevent biofilm formation on the patient at thesurgical site and facilitate a healing of the patient's tissue at thesurgical site.

The transducer may be affixed to a carrier pad, the placing of thetransducer on the patient including attaching the pad to the patient.Alternatively, the transducer may be disposed in a balloon or bladderinflated with a gel or other medium conducive to the effectivetransmission of ultrasonic pressure waves, the balloon or bladder beingattached to the patient over or adjacent the surgical site. Othertransducer carriers and methods of attachment to the patient will occurto those skilled in the art.

Accordingly, a medical therapeutic method comprises (a) removingnecrotic tissue and undesired organic material from a surgical site on apatient, (b) shortly thereafter, while the surgical site is free ofdiscernible bacteria, placing at least one ultrasonic transducer on thepatient at least proximate the surgical site, and (c) after the placingof the transducer and while the transducer is in effectivevibration-transmitting contact with the patient, conducting anelectrical energization waveform of an ultrasonic frequency to thetransducer at least intermittently during a period of approximately oneday or longer, the waveform having frequency, amplitude and duration toeffectively reduce formation on the patient at the surgical site andthereby facilitate a healing of the patient's tissue at the surgicalsite. The placing of the transducer preferably includes removablyattaching the transducer to the patient atop tissues at the surgicalsite.

A surgical device comprises an ultrasonic probe having an operative tip,an electromechanical transducer operatively connected to the probe forgenerating an ultrasonic standing wave in the probe, and at least onesheath or sleeve disposed about the probe and defining at least a firstsuction port at a distal end of the probe, proximate the operative tip,and a second suction port spaced from the distal end of the probe.

The one or more sheaths or sleeves may take the form of exactly onesheath or sleeve slidably attached to the probe to shift between adistal position and a proximal position, wherein a distal end of thesheath or sleeve is alternately locatable (i) proximate the operativetip to define the first suction port and (ii) at a predetermineddistance from the operative tip to define the second suction port.

Alternatively, the first suction port and the second suction port aredifferent openings in the at least one sheath or sleeve. Theiroperational status may be separately controlled via respective valves.Moreover, the suction ports may be connectable to vacuum sources ofdifferent strengths. The magnitude of the vacuum or negative pressureapplied to the proximal port is typically greater than the magnitude ofthe vacuum or negative pressure applied to the distal port.

The sheath or sleeve may define a first suction channel extending to thefirst suction port and a separate second suction channel extending tothe second suction port, the first suction channel and the secondsuction channel being subjectable to different negative pressures.

Described herein is a method for bacterial containment duringapplication of therapeutic ultrasound application. In a preferredembodiment, a suction device is incorporated adjacent to the therapeuticultrasound applicator to create a path of removal for any bacteria thatis being displaced during the treatment. The suction device isincorporated in such a way as to orient the orifice of the suction tofavorably capture any projected, predicted or anticipated paths of spraythe would result from the applicator tip interacting with the targetedtreatment site. In this the suction device is optimized for thepreferential capture of any bacteria that is displaced by the tissueremoval during debridement. The suction device can also be used tocontain irrigation spray that results from the application oftherapeutic ultrasonic energy.

In another embodiment the suction device is integrated into thetreatment probe so that is has ports of capture that are strategicallyplaced to remove bacteria that is displaced during tissue removal duringdebridement. The suction device is incorporated in such a way as toorient the orifice of the suction to favorably capture any projected,predicted or anticipated paths of spray the would result from theapplicator tip interacting with the targeted treatment site. The suctiondevice can also be used to contain irrigation spray that results fromthe application of therapeutic ultrasonic energy.

In another embodiment the suction device is separate from the treatmentprobe but is used in coordination to capture any bacteria that isdisplaced by the tissue removal during debridement. The suction devicecan be strategically placed adjacent to the treatment area in such amanner that the opening of the suction device creates a preferentialpath for the capture of displaced bacteria. The suction device can be aring that defines a specific treatment area around the ultrasoundapplicator. The ring device has capture ports that are oriented inwardtowards the potential treatment areas so that in any direction captureof bacteria that is displaced from the treatment site. The suctiondevice is incorporated in such a way as to orient the orifice of thesuction to favorably capture any projected, predicted or anticipatedpaths of spray the would result from the applicator tip interacting withthe targeted treatment site. The suction device can also be used tocontain irrigation spray that results from the application oftherapeutic ultrasonic energy. The suction device can be secured to thepatient temporarily so that it creates a barrier for the bacteria orirrigation spray to be able to get beyond. The temporary attachment canbe a strap, a skin friendly adhesive pad, or another easy to place easyto remove approach.

In another embodiment, a suction device is incorporated adjacent to thetherapeutic ultrasound applicator to create a path of removal for anybacteria that is being displaced during the treatment. The suctiondevice has two or more position of use. In the first position thesuction device is incorporated in such a way as to orient the orifice ofthe suction to favorably capture any projected, predicted or anticipatedpaths of spray the would result from the applicator tip interacting withthe targeted treatment site. In this the suction device is optimized forthe preferential capture of any bacteria that is displaced by the tissueremoval during debridement. In the second position the suction device isincorporated in such an way to come into direct contact with thetargeted treatment surface to allow for direct removal of any residualbacteria. The suction device can also be used to contain irrigationspray that results from the application of therapeutic ultrasonicenergy.

In another embodiment suction device is incorporated into a therapeuticultrasound applicator that delivers an irrigation stream to theapplicator tip. The suction device is a disposable sheath incorporatedadjacent to the therapeutic ultrasound applicator to create a path ofremoval for any bacteria or irrigation spray that is being displacedduring the treatment. The suction device is incorporated in such a wayas to orient the orifice of the suction to favorably capture anyprojected, predicted or anticipated paths of spray the would result fromthe applicator tip interacting with the targeted treatment site. In thisthe suction device is optimized for the preferential capture of anybacteria that is displaced by the tissue removal during debridement. Thesuction device can also be used to contain irrigation spray that resultsfrom the application of therapeutic ultrasonic energy.

In another embodiment suction device is incorporated into a therapeuticultrasound applicator that delivers an irrigation stream to theapplicator tip. The suction device is a disposable sheath that is moldedonto the single use ultrasound treatment probe to create a path ofremoval for any bacteria or irrigation spray that is being displacedduring the treatment. The suction device is incorporated in such a wayas to orient the orifice of the suction to favorably capture anyprojected, predicted or anticipated paths of spray the would result fromthe applicator tip interacting with the targeted treatment site. In thisthe suction device is optimized for the preferential capture of anybacteria that is displaced by the tissue removal during debridement. Thesuction device can also be used to contain irrigation spray that resultsfrom the application of therapeutic ultrasonic energy.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is partially a schematic cross-sectional view and partially ablock diagram of a system for removing biofilm from a wound site andreducing the likelihood of biofilm reformation thereafter.

FIG. 2 is partially a schematic cross-sectional view and partially ablock diagram of another apparatus for removing biofilm from a woundsite and reducing the likelihood of biofilm reformation thereafter.

FIG. 3 is partially a schematic cross-sectional view and partially ablock diagram of yet a further apparatus for removing biofilm from awound site and reducing the likelihood of biofilm reformationthereafter.

FIG. 4 is partially a schematic cross-sectional view and partially ablock diagram of a device for attachment to a patient at a wound site,to reduce the likelihood of biofilm formation on the wound site.

FIG. 5 is a schematic top plan view and partially a block diagram of thedevice of FIG. 4, in position and attached to a patient at a wound siteon the patient.

FIG. 6 is a schematic perspective view of another device for attachmentto a patient at a wound site, to reduce the likelihood of biofilmformation.

FIG. 7 is partially a schematic cross-sectional view and partially ablock diagram of a device for attachment to a patient at a wound site,to reduce the likelihood of biofilm formation on the wound site, showingattachment of the device to a patient's limb.

FIG. 8 is a schematic longitudinal cross-sectional view of a distal endportion of an ultrasonic instrument assembly in accordance with theresent invention.

FIG. 9 is a partial longitudinal cross-sectional view of a device fordebriding or removing biofilm from a wound site in accordance with thepresent invention.

FIG. 10 is a schematic right side, top and front perspective view of thedevice of FIG. 9.

FIG. 11 is an exploded right side, top and front perspective view of aprobe and sheath included in the device of FIGS. 9 and 10.

FIG. 12 is an exploded left side, top, and rear perspective view of theprobe and sheath of FIGS. 9-11.

FIG. 13 is a rear elevational view of the probe and sheath of FIGS.9-12.

FIG. 14 is a partial cross-sectional view, similar to FIG. 9, takenalong line XIV-XIV in FIG. 13.

FIG. 15 is a right side, top and front perspective view of anotherdevice for debriding or removing biofilm from a wound site in accordancewith the present invention.

FIG. 16 is a partial right side, top and front perspective view, on anenlarged scale, of a distal tip portion of the device of FIG. 15.

FIG. 17 is a partial right side, top and front perspective view, on anenlarged but intermediate scale, of a distal end portion of the deviceof FIGS. 15 and 16.

FIG. 18 is a left side, bottom, and front perspective view, on anenlarged scale, of the device of FIGS. 15-17.

FIG. 19 is a schematic perspective view of a suction device inaccordance with the present invention, in place around a surgical site.

DETAILED DESCRIPTION

The present disclosure contemplates a two phase method for reducing theformation of biofilm. The first phase is performed where a wound site isbeing treated for removal of necrotic tissue, eschar or biofilm andincludes an evacuation of ambient air from a region about the surgicalor treatment site, to extract airborne or aerosolized bacteria ejectedfrom the site by the treatment. The extracted bacteria are preventedfrom settling back onto the cleansed tissue surface, thus at leastreducing colonial bacteriological growth and concomitantly exudedbiofilm material. The second phase or approach for reducing biofilminvolves the attachment of one or more ultrasonic transducers to thepatient over or near a surgical treatment site after the surgery isterminated. Each applied ultrasonic transducer is used to vibrate thepatient's tissues at the treatment site to disrupt biofilm formation.The two phases of treatment may be used separately depending on theapplication. Thus, ultrasonic biofilm disruption may be used at woundsites which have not been subjected to formal processes for removal ofnecrotic tissue, eschar or biofilm.

Accordingly, a medical therapeutic method may utilize an ultrasonicdebridement instrument 10 (FIG. 1) having an operative tip or surface 12and a suction channel 14 defined between an outer surface 16 of anultrasonic horn 18 and an inner surface 20 of a cannula or sheath 22.The method comprises manipulating the instrument 10 to place theoperative tip or surface 12 against a patient's tissues PT at apreselected surgical site SS. During contact of the operative tip 12with the patient's tissues PT, one operates a waveform generator 23 togenerate an ultrasonic standing wave in the instrument 10 andparticularly in probe or horn 18, to thereby fragment necrotic tissueand undesired organic material at the surgical site SS. During thegenerating of the ultrasonic standing wave, a suction inlet 24 at adistal end of the suction channel 14 is disposed proximate the surgicalsite SS and a vacuum or negative pressure is applied to the suctionchannel 14 to suck tissue debris and fragmented organic material fromthe surgical site SS via the suction inlet 24. A suction port 26 ofanother instrument 28 is disposed at a position spaced at a distance D1from the surgical site SS. During and/or after the generating of theultrasonic standing wave and the fragmenting of tissue and material byinstrument 10, instrument 28 is operated to suck ambient air, asindicated by arrows 30, from a region R about the surgical site SSthrough suction port 26. While suction inlet 24 is typically locatedbetween 1 and 5 mm from the surgical site SS and the tissue surface atthe surgical site, suction port 26 is typically located 2-6 cm from thetissue surface at the surgical site SS.

As depicted in FIG. 1, instrument 28 may be formed at a distal end withan enlarged or expanded extension 32, such as a cone, to funnel air 30into the instrument. A suction source or vacuum generator 34communicating with a lumen 36 of instrument 28 may exert a greatersuction force than that of a suction source or vacuum generator 38communicating with suction channel 14.

In an alternative approach, instrument 28 is omitted. Instead, cannulaor sheath 22 is shiftably mounted to probe or horn 18 for longitudinalmotion alternately in opposing directions along the shaft or probeportion thereof, thereby enabling the user to position the suction port,defined in part by the distal edge of the sheath, in two or morealternative locations, a most distal location adjacent the operative tip18 of the probe or horn 12 and a more proximal location. As indicated bya double headed arrow 40, cannula or sheath 22 is pulled in a proximaldirection after an operation removing tissue or other organic matterfrom surgical site SS so that suction port 26 is located at a distance dfrom the operative tip or surface 12 of instrument 10. An actuator suchas suction source 38, or a switch component thereof, is operated toenable the sucking of air through suction port 26 at the retractedposition of cannula or sheath 22. In a simple configuration, suctionsource 38 may have twp operating states, on and off, the position ofsheath 22 determining whether suction is applied at the surgical site SSor at a distance therefrom. In a slightly more complicatedconfiguration, suction source 38 may be provided with three operatingstates, namely, off, high suction and low suction. The degree of suctionmay be selectable by the operator or may be automatically controlled inaccordance with the longitudinal or axial position of sheath 22 alongprobe or horn 12. For instance, sheath or sleeve 22 may be provided withvalves (not shown) for opening and closing air pathways in dependence onthe longitudinal position.

An alternative instrument assembly 50 depicted in FIG. 2 has anoperative tip or surface 52 and a suction channel 54 located between anouter surface 56 of an ultrasonic horn 58 and an inner surface 60 of afirst or inner sheath 62. A second, outer, sheath 64 surrounds the firstsheath 62 and defines therewith a second suction channel 66 for theevacuation of ambient air from a sizable region R′ about the surgicalsite, exemplarily through a conical port element 68 at the distal end ofthe outer sheath 64. The two suction channels 54 and 66 may be connectedto respective suction sources or vacuum generators 70 and 72 viarespective valves 74 and 76 both actuatable by the operator via acontrol unit 78. Control unit 78 is tied to a control input (notseparately designated) of an ultrasonic waveform generator 80 that isoperatively connected to probe or horn 12 via an electromechanicaltransducer (not shown) such as a stack of piezoelectric crystals.Control unit 78 may be programmed to open valve 76 within a selectabletime interval after the opening of valve 74 and the activation ofwaveform generator 80.

In a surgical procedure, instrument assembly 50 is manipulated to placethe operative tip or surface 52 against patient's tissues PT′ at apreselected surgical site SS′. During contact of the operative tip 52with the patient's tissues PT′, control unit 78 is operated to activatewaveform generator 80, which generates an ultrasonic standing wave inprobe or horn 58, to thereby fragment necrotic tissue and undesiredorganic material at the surgical site SS′. During the generating of theultrasonic standing wave, a suction inlet 82 at a distal end of innersuction channel 54 is disposed proximate the surgical site SS′ and avacuum or negative pressure is applied by suction source 70 to thesuction channel 54 via valve 74 to suck tissue debris and fragmentedorganic material from the surgical site SS′ through the suction inlet82. Conical port element 68 is disposed at a distance D2 from thesurgical site SS′. During and/or after the generating of the ultrasonicstanding wave and the fragmenting of tissue and material by instrument50, vacuum generator 72 and valve 76 are actuated by control unit 78 tosuck ambient air, as indicated by arrows 84, from region R′ throughsuction port or cone 68. Suction inlet 82 is typically located a minimaldistance, exemplarily between about 1 and about 5 mm, from tissues atthe surgical site SS′ while suction port 68 distance D2 is typically 2-6cm from the surgical site SS′.

Outer sheath 64 may be temporarily fixed to inner sheath 62 via aquick-release lock 86 such as a set screw. Thus, the relative axialpositions of sheaths 62 and 64 may be adjusted to change distance D2.Control unit 78 may be connected to suction sources or vacuum generators70 and 72 for varying the power usage thereof and average magnitudes ofthe negative pressures generated thereby.

FIG. 3 illustrates a modification of the instrument assembly 50 of FIG.2. Instead of outer sheath 64, a suction nozzle 92 is attached to sheath62. Nozzle 92 is connected to suction source or vacuum generator 72 viaa reinforced hose 94. Nozzle 92 is removably secured to sheath 62 via alocking element 96 such as a ring clamp or a set screw. The operation ofmodified instrument 90 is as discussed above.

The present method alternatively or additionally comprises placing anultrasonic transducer 102 (see, e.g., FIGS. 4 and 5) in effectivecontact with a patient TP at least proximate a surgical site SI afterterminating of a debridement or other tissue cleaning procedure andwhile the surgical site SI is free of discernible bacteria. Typically,transducer 102 is placed immediately after the surgical site SI has beencleaned of necrotic tissue and other undesirable debris and even priorto the removal of the patient TP from the operating room. After theplacing of transducer 102 and while the transducer is in effectivevibration-transmitting contact with the patient TP, an electricalenergization waveform of an ultrasonic frequency is conducted from awaveform generator 104 to transducer 102 at least intermittently duringa period of approximately one day or longer to reduce, if not prevent,biofilm formation on the patient at the surgical site SI and therebyfacilitate a healing of the patient's tissue at the surgical site.

As depicted in FIG. 4, transducer 102 may be affixed to a carrier pad106, exemplarily sandwiched between layers 108 of a biocompatible andultrasound transmitting material. The placing of transducer 102 on thepatient TP preferably includes attaching pad 106 to the patient, forexample, via an adhesive layer 110. As depicted in FIG. 5, pad 106 isdisposed alone or together with one or more other carrier pads 106′, ona tissue surface TS proximate surgical site SI. Alternatively, pad 106may be placed directly over the surgical site SI shortly, if notimmediately, after tissue removal is complete. In that case adhesivelayer 110 may be omitted in favor of a layer of gel. The gel may beoxygenated and contain antibiotics. As depicted in FIG. 6, straps orbands 112 may be provided for securing the pad 106 to the patient TP.

Alternatively, as depicted in FIG. 7, an electromechanical,specifically, a piezoelectric, transducer 114 may be disposed inside aballoon or bladder 116 inflated with a gel or other medium 118 conduciveto the effective transmission of ultrasonic pressure waves, the balloonor bladder being attached to a patient TP′ over or adjacent a surgicalsite SI′. Balloon or bladder 116 is affixed to a patient, e.g., aroundan arm or leg PL, over or near a surgical site ST and an ultrasonicwaveform generator 120 is activated to generate ultrasonic vibrationsconducted into the patient's tissue to disrupt biofilm formation. Othertransducer carriers and methods of attachment to the patient will occurto those skilled in the art.

A medical therapeutic method utilizing one or more of the transducerdevices shown in FIGS. 4-7, first comprises cleaning surgical site SI orST of necrotic tissue and undesired organic material, for instance viaultrasonic debridement and suction as discussed above with reference toFIGS. 1-3. Shortly thereafter, while the surgical site SI or ST is freeof discernible bacteria, one places at least one ultrasonic transducer102, 114 on the patient TP, TP′ proximate or on the surgical site SI,ST, and thereafter, while the transducer is in effectivevibration-transmitting contact with the patient TP, TP′, conducting anelectrical energization waveform of an ultrasonic frequency to thetransducer 102, 114 at least intermittently during a period ofapproximately one day or longer. The waveform has frequency, amplitudeand duration parameters selected to effectively reduce biofilm formationon the patient TP, TP′ at the surgical site SI, ST and therebyfacilitate a healing of the patient's tissue at the surgical site. Theultrasound generates a surface acoustic wave, exemplarily at 20 kHz,illustratively with an acoustic power output of 0.2-0.4 w/cm². Thetreatment period is long enough to enable healthy tissue formation. Theplacing of the transducer 102, 114 preferably includes removablyattaching the transducer to the patient atop tissues at the surgicalsite SI, ST.

As depicted in FIG. 8, an ultrasonic surgical device 200 comprises anultrasonic probe 202 that is operatively connected to a source 204 ofultrasonic vibratory energy including an ultrasonic signal generator 206and a stack of piezoelectric crystals 208 for vibrating at an ultrasonicfrequency as symbolized by a double-headed arrow 210. Probe 202 extendslongitudinally through an inner sheath 212 that is provided at a distalend region with one or more apertures 214, 216. Probe 202 and sheath 212define an annular inner channel 218 that is connected at a proximal endof the instrument to a suction or vacuum source 220. An outer sheath 222surrounds the inner sheath 212 and defines therewith an annular outerchannel 224.

During use of the surgical device or assembly 200 of FIG. 8, irrigantflows from a supply 226 through an inlet port 228 and into outer channel224, as indicated by arrows 230. The irrigant exits the outer channel224 along two paths, firstly through a distal end opening 232, perarrows 234, 236, and secondly through apertures 214, 216 into innerchannel 218 where the liquid or irrigant is drawn in a proximal action,as indicated by arrows 238, toward suction source 220.

At a surgical site 240, tissue fragments 242 and 244 are separated byultrasonic vibration of a distal end surface 246 of probe 202 placedinto contact with the surgical site. A vacuum underpressure at thedistal end (not designated) of inner channel 218 draws tissue fragments242, 244 into the inner channel, together with irrigant present at thesurgical site 240 owing to outflow from outer channel 224 via distal endopening 232. Further irrigant entering inner channel 218 via apertures214, 216 facilitates emulsion flow.

Device or assembly 200 is different from surgical aspirators wheredisrupted tissue is being aspirated through the center of a mostlycylindrical cannulated probe or small cross-section. In device 200 ofFIG. 8, the dual irrigant capture scheme facilities the delivery ofsufficient liquid to ensure the occurrence of cavitation as well as tomaintain safe temperature levels of both the probe 202 and the tissue atthe surgical site 240. By capturing liquid via apertures 214, 216,before the irrigant can reach the surgical site 240, the device 200reduces the volume of liquid that could be atomized by the probe 202.

The reduction of atomized irrigant is even more desirable in wounddebridement procedures. This is due to the much larger size of the probetip area normally used for large scale debridement, which is up to 80times that of surgical aspirator probes, and also due to the largervolumes of irrigant required to maintain safe temperature levels in thetissue and probe.

As depicted in FIGS. 9 and 10, a surgical device 300 for debriding orremoving biofilm from a wound site comprises an ultrasonic probe 302which is attached at a proximal end via threaded connector 304 to adriver 306 is operatively connected to a generator of vibratory energy,typically a piezoelectric transducer array (not shown). Both the driver306 and the piezoelectric transducer are located in a handpiece whichhas a cover or housing (not shown) connected to a casing 308. Probe 302tapers down on a distal side to a distal end section 310. It is to benoted that the terms “horn” and “probe” are used synonymously.

Driver 306 and probe 302 are formed with mutually aligned axial channelsor bores 312 and 314 that define a lumen (not separately designated) forthe delivery of irrigant to a distal end aperture 316 in probe hornsection 310, as indicated by flow arrows 318.

Surgical device 300 further includes a rigid sheath 320 that isshiftably mounted to casing 308 to vary a position of a distal tip 322of the sheath relative to a distal tip or end face 324 of probe 302.Sheath 320 includes a cylindrical rear section 326 and a rectangularlyprismatic forward section 328, which correspond geometrically tocross-sections of horn 310 and a proximal portion 330 of probe, 302,respectively.

Together with an outer surface (not designated) of probe horn 310,forward sheath section 328 defines a forward or distal channel orconduit 332, which is rectangular in cross-section. Together with anouter surface (not designated) of proximal probe portion 330, rearsheath section 326 defines a rearward or proximal channel or conduit334, which is circular in cross-section. At a distal end, rearwardchannel 334 expands to an enlarged space 336 owing to the tapering ofthe probe at 338.

Sheath 320 is provided with an arm 340 that is connected at a forward ordistal end to forward section 326 and is angled outwardly at a proximalside. Sheath arm 340 includes a main aspiration channel 342 thatcommunicates at a distal end with forward channel 332. At a moreproximal location, aspiration channel 342 of arm 340 communicates withrearward channel 334 and more particularly with enlarged space 336. At aproximal end, arm 340 is provided with an undercut connector port 344which receives a resilient aspiration tube 346 in a friction fit.Aspiration tube 346 is fastened to casing 308 via a pair of clips 348each formed with a pair of slotted annular rings 350 and 352 forreceiving casing 308 and aspiration tube 346, respectively.

At a forward or distal end, probe horn 310 is formed with one or moreapertures or cross-bores 354 and 356 that communicate on an inner sidewith channel or lumen 314 and on an outer side with forward channel 332.At a rear end, rear section 326 of sheath 320 is inserted betweenproximal probe portion 330 and a distal end of casing 308. An O-ringseal 358 is provided between casing 308 and an outer surface of sheathrear section 326.

A distal end of horn section 310 is formed into a probe head 360 that isextended in a traverse dimension, orthogonally to a longitudinal axis ofthe probe 302. Head 360 may particularly take a form disclosed in U.S.patent application Ser. No. 14/172,566, Publication No. 2015/0216549,the disclosure of which is incorporated by reference herein. Inparticular, head 360 includes a plurality of teeth 362 arranged in twomutually parallel rows along opposing edges or sides of the distal endface 324 of the probe head.

As indicated above, sheath 320 is slidable or longitudinally shiftablerelative to probe 302 so as to be continuously adjustable as to axial orlongitudinal position relative to probe head 360 anywhere from a fullyextended position, where the distal tip 322 of sheath 320 is essentiallycoplanar with the distal end face 324 of probe head 360, to a retractedposition where at least the teeth 362 of probe head 360 are fullyexposed. O-ring 358 enables the adjustable positioning of sheath 320.

Apertures or cross-bores 354 and 356 serves as bypass holes, regardlessof the relative longitudinal positioning of sheath 320 and probe 302. Avacuum under-pressure applied to the internal spaces of sheath 320,i.e., aspiration channel 342, forward channel 332, and rearward channel334, by a suction source (not shown) enables the capturing and removalof most of the irrigant that is delivered through central channel 314(flow arrows 318). Accumulation of irrigant within sheath 320,especially when the device is used in a predominantly verticalorientation, is prevented by the provision of two suction pathways,namely, between aspiration channel 342 and each of the forward channel332 and rearward channel 334. Irrigant not captured via a distal pathwayis captured in a proximal pathway.

Where tissue fragments are small enough to be aspirated through the gapbetween the probe 302 and the sheath 320, clogging is prevented bydesigning the aspiration pathway of channel 324 to gradually increase incross-sectional area from the probe-sheath gap at the distal end of theinstrument all the way to the aspiration line. A vent port 364 may beprovided in the rear sheath section 326 to reduce the magnitude ofvacuum-generated pull force acting on the tissue which is driven towardsand into the probe-sheath gap during debridement.

Matching or cooperating features 366 and 368 are respectively disposedon the outer side of the probe 302 and the inside of rear sheath section326, in close proximity to a nodal plane or the probe, to facilitateprobe-sheath alignment. This minimizes the chances of a probe-sheathcontact at the points of maximum vibratory motion (antinodes),particularly at end face 324 of probe head 360. Due to their placementat a location of minimal vibratory displacement, e.g., the junction 370between cylindrical probe portion 330 and tapering probe section 338,the alignment features 366 and 368 allow for the probe-sheath contactnecessary for preventing or minimizing the unwanted interaction in thearea of maximum vibratory displacement.

As depicted in FIGS. 15-18, another ultrasonic surgical device 400 fordebriding or removing biofilm from a wound site comprises a handpiece402 provided at a distal end with a sheath 403 and a suction orevacuation attachment 404 swingably attached to the sheath at pivot pins406 (only one shown). An ultrasonic probe is disposed inside handpiece402 and sheath 403 and terminates and a distal end in a head 408 formedwith crenulations or teeth 410.

Suction attachment 404 includes a body portion 412 at a proximal end anda pair of hollow arms 414, 416 extending in a distal direction from thebody portion. Arms 414 and 416 are joined to one another at their distalend by a cross-piece 418 serving as a suction head. As shown in FIG. 18,suction head 418 is formed on a lower side with a plurality oflongitudinally extending runners or ribs 420 and a recess 422, which isbridged by the runners or ribs and which communicated with aspirationchannels (not shown) in the hollow arms 414, 416. Body portion 412 isprovided with a port connector 424 to which an aspiration tube (liketube 346) is attached. Liquid irrigant is guided to an outlet port (notshown) in probe head 408 via a channel (not shown) in the probe. Theirrigant, together with tissue fragments and other surgically generateddebris, is drawn from the surgical site via suction attachment 404. Moreparticularly, during a debridement operation, suction head 418 is placedin essential contact with the tissue at the surgical site. Irrigant andtissue debris are collected via recess 422 and guided through arms 414and 416 and out through port connector 424.

The pivotable mounting of suction attachment 404 enables suction head418 and particularly recess 422 to remain juxtaposed to a tissue surfaceeven as the rest of the instrument particularly handpiece 402, sheath403 and the probe are tilted to assume different angles relative to anormal to the tissue surface.

FIG. 19 shows a suction device 500 in the form of a ring that is placedon a tissue surface 502 for purposes of removing airborne particlesgenerated by use of an ultrasonic instrument 504 on tissue at a surgicalsite 506. Ring 500 is provided along an inner cylindrical surface with aplurality of spaced suction ports 508. Ports 508 may be tiltably mountedto the ring 500, e.g., via universal joints that have joint balls 509that are perforated. Ring 500 is at least partially hollow so thatsuction ports 508 may communicate via a hose 510 with a suction source(not shown). Ring 500 may be attached to a patient, e.g., to a limb 512,via one or more of various coupling devices, such as a strap 514 withbuckles or hook-and-loop fabric fasteners, or an adhesive layer 516.

Although the invention has been described in terms of particularembodiments and applications, one of ordinary skill in the art, in lightof this teaching, can generate additional embodiments and modificationswithout departing from the spirit of or exceeding the scope of theclaimed invention. Moreover, the phase shift might be varying, forinstance, where the vibration modes are of different frequencies.Accordingly, it is to be understood that the drawings and descriptionsherein are proffered by way of example to facilitate comprehension ofthe invention and should not be construed to limit the scope thereof.

1-5. (canceled)
 6. A medical therapeutic method comprising: providing anultrasonic debridement instrument having an operative tip; manipulatingsaid instrument to place said operative tip in effective proximity to apatient's tissues at a preselected surgical site; after placing of saidoperative tip in effective proximity to the patient's tissues,generating an ultrasonic standing wave in said instrument, to therebyfragment necrotic tissue and other undesired organic material at saidsurgical site; placing at least one ultrasonic transducer on the patientat least proximate the surgical site after terminating of a debridementprocess and while the surgical site is free of discernible bacteria; andafter the placing of said transducer and while said transducer is ineffective vibration-transmitting contact with the patient, conducting anelectrical energization waveform of an ultrasonic frequency to saidtransducer at least intermittently during a period of approximately oneday or longer to at least reduce biofilm formation on the patient at thesurgical site and facilitate a healing of the patient's tissue at thesurgical site.
 7. The method defined in claim 6 wherein said transduceris affixed to a carrier pad, the placing of said transducer on thepatient including attaching said pad to the patient.
 8. The methoddefined in claim 6, further comprising utilizing said instrument at alower energy setting to pre-condition the tissues at the surgical sitefor disrupting adherence or starting the formation of biofilm. 9.(canceled)
 10. A medical therapeutic method comprising: ultrasonicallyremoving necrotic tissue and other undesired organic material from asurgical site on a patient; after the removal of all discerniblenecrotic tissue and other undesirable organic material from the surgicalsite and while the surgical site is free of discernible bacteria,placing at least one ultrasonic transducer on the patient spaced fromthe surgical site; and after the placing of said transducer and whilesaid transducer is in effective vibration-transmitting contact with thepatient, conducting an electrical energization waveform of an ultrasonicfrequency to said transducer at least intermittently during a period ofapproximately one day or longer, said waveform having frequency,amplitude and duration to effectively reduce biofilm formation on thepatient at the surgical site and thereby facilitate a healing of thepatient's tissue at the surgical site.
 11. The method defined in claim10 wherein the placing of said transducer includes removably attachingsaid transducer to the patient.
 12. The method defined in claim 11wherein the placing of said transducer includes removably attaching saidtransducer atop tissues spaced from the surgical site.
 13. The methoddefined in claim 11 wherein said transducer is affixed to a carrier pad,the placing of said transducer on the patient including attaching saidpad to the patient.
 14. The method defined in claim 10 wherein theremoving of necrotic tissues includes operating an ultrasonic debriderinstrument at a first energy setting, further comprising utilizing saidinstrument at a lower second energy setting to pre-condition the tissuesat the surgical site for disrupting adherence or starting the formationof biofilm. 15-19. (canceled)
 20. An ultrasonic debridement instrumentassembly comprising: a probe including a proximal body section, asmaller-diameter horn section, and a probe head, the horn sectionextending distally of said body section, said head being formed at adistal end of said horn section; and a rigid sheath shiftable relativeto said probe for assuming multiple longitudinal positions relative tothe probe, said probe having a longitudinal channel for the delivery ofliquid irrigant to an outlet in a surface or face of said probe head,said probe and said sheath defining a first space or channel and asecond space or channel, said second space or channel being locatedproximally of said first space or channel and having a larger transversecross-sectional area, in a plane orthogonal to an axis of said probe,than a transverse cross-sectional area of said first space or channel,said probe being provided in a distal end portion with at least oneaperture spaced from said outlet and communicating with said first spaceor channel, said sheath being configured to shift between a distal-mostposition wherein said probe head is covered and a proximal-most positionwherein at least a portion of said probe head is exposed, said sheathbeing provided with an aspiration channel communicating with said firstspace or channel and said second space or channel.
 21. The ultrasonicdebridement instrument assembly defined in claim 20 wherein said rigidsheath includes a cylindrical rear section and a rectangularly prismaticforward section.
 22. The ultrasonic debridement instrument assemblydefined in claim 21 wherein said proximal body section is cylindricaland defines with said cylindrical rear section of said rigid sheath saidsecond space or channel, said rectangularly prismatic forward section ofsaid rigid sheath and said smaller-diameter horn section defining saidfirst space or channel.
 23. The ultrasonic debridement instrumentassembly defined in claim 22 wherein said probe and said rigid sheathdefine an enlarged space or chamber between said first space or channeland said second space of channel.
 24. The ultrasonic debridementinstrument assembly defined in claim 23 wherein said aspiration channelof said aspiration arm communicates directly with said enlarged space orchamber.
 25. The ultrasonic debridement instrument assembly defined inclaim 23 wherein said aspiration channel of said aspiration arm is indirect communication with said first space or channel, distally of saidenlarged space or chamber.
 26. The ultrasonic debridement instrumentassembly defined in claim 25 wherein said rigid sheath includes a rearsheath section inserted inside a handpiece casing, an O-ring seal beingdisposed between an outer surface of said rear sheath section and saidhandpiece casing.
 27. The ultrasonic debridement instrument assemblydefined in claim 26 wherein said probe head includes a plurality ofteeth arranged in two mutually parallel rows along opposing edges orsides of a distal end face of said probe head.
 28. The ultrasonicdebridement instrument assembly defined in claim 20 wherein said probeand said rigid sheath define an enlarged space or chamber at a junctionof said proximal body section and said smaller-diameter horn section,said aspiration channel communicating directly with or opening into saidenlarged space or chamber.
 29. The ultrasonic debridement instrumentassembly defined in claim 20 wherein said aspiration channel of saidaspiration arm is in direct communication with said first space orchannel, distally of a junction between said proximal body section andsaid smaller-diameter horn section.
 30. The ultrasonic debridementinstrument assembly defined in claim 20 wherein said rigid sheathincludes a rear sheath section inserted inside a handpiece casing, anO-ring seal being disposed between an outer surface of said rear sheathsection and said handpiece casing.
 31. The ultrasonic debridementinstrument assembly defined in claim 20 wherein said probe head includesa plurality of teeth arranged in two mutually parallel rows alongopposing edges or sides of a distal end face of said probe head.